Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Gene Ontology Database

By Biotechdaily staff writers
Posted on 13 Jul 2005
A database that classifies thousands of human genes by their biologic processes, molecular function, or cellular components is being aided by new bioinformatics technology that guesses the appropriate category for genes not yet classified.

The Gene Ontology database (www.geneontologyt.org) is being developed by the Gene Ontology Consortium, supported by a grant from the U.S. More...
National Genome Research Institute (NHGRI, Washington, DC, USA).

Biomind LLC (Rockville, MD, USA; www.go.biomind.com) is now applying advanced machine learning algorithms to guess the appropriate category for classifying hundreds of previously unclassified genes. The Biomind software makes its guesses by combining information about gene sequences with data mined from a large body of microarray data, incorporating data from a variety of different experiments. The results of this analysis are available on the company's website.

The basic concept is that if a gene behaves and looks similar to the genes in some Gene Ontology category, such as "DNA repair” or "glycolysis,” then perhaps the gene belongs in that category. However, it is not always that simple. "Getting from this basic concept to a working classification system with high accuracy involves a lot of computer science,” explained Dr. Ben Goertzel, CEO of Biomind. Statistical testing suggests that the system's prediction will be roughly 80% accurate, and this accuracy may be improved in the near future by utilizing a broader collection of microarray data.

According to Dr. Goertzel, this information on gene function "should be interesting to anyone doing genomics research. It suggests possible functions for a whole lot of genes that were previously not understood at all, some that were never mentioned in the research literature, because the biologists haven't gotten around to studying them yet. For instance, there are dozens of genes that our software says are associated with programmed cell death--a key cause of aging--and that weren't previously known to have anything to do with anything.”





Related Links:
Gene Ontology
Biomind

Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Benchtop Thermomixer
Biometra TS1 ThermoShaker
New
Total Laboratory Automation Solution
SATLARS Mini T8
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.